3320 — China Resources Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapContrarian

Annual balance sheet for China Resources Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	38,587	47,067	46,522	32,231	25,648
Net Total Accounts Receivable
Net Total Receivables	55,927	62,772	67,872	102,607	110,327
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	123,819	143,903	152,259	178,568	185,846
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,266	20,804	22,092	25,376	26,339
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	176,225	202,531	215,534	246,770	257,760
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	103,207	115,151	121,770	134,233	132,222
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	137,112	160,991	171,977	200,811	209,516
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	39,113	41,540	43,557	45,960	48,244
Total Liabilities & Shareholders' Equity	176,225	202,531	215,534	246,770	257,760
Total Common Shares Outstanding